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A novel method is described which facilitates the in vitro assembly of one step in the life cycle of vaccinia virus, the
formation of the spherical immature virus (IV). For this, advantage was taken of the ability of rifampicin to reversibly block
the assembly of the IV. Rifampicin-treated, vaccinia virus-infected HeLa cells were permeabilized with streptolysin O (SLO)
and the endogenous cytosol was allowed to exit the cells at 47. Subsequently, exogenous cytosol from infected or uninfected
HeLa cells as well as an ATP-regenerating system were added and the cells were incubated for different times at 377 in
the absence of rifampicin. The preparations were then evaluated by thin section EM. Our data show that in the presence
of infected or uninfected cell cytosol and ATP a significant fraction of cells could reconstitute IV assembly in vitro. Under
no conditions were we able to reconstitute any later stages of assembly. The potential of this system for the in vitro
reconstitution of viral assembly in general is discussed. q 1997 Academic Press
INTRODUCTION cisternal membranes of the intermediate compartment
of the host cell (Sodeik et al., 1993), a compartment that,
Following DNA replication in the cytoplasm of a newly
according to our data, is a subdomain of the ER (Griffiths
infected cell, vaccinia virus undergoes a unique se-
et al., 1994; Krijnse Locker et al., 1994; summarized in
quence of morphogenic events, involving membranes of
Griffiths, 1996). One of the key proteins that, directly or
the host cell (Dales and Pogo, 1981; Moss, 1990). After
indirectly, interacts with the viral crescent is p65, localiz-
3–4 hr of infection two large structures are visible even
ing specifically to the inner, concave aspect of the devel-
by light microscopy in the infected cell—the DNA-en-
oping crescent. Genetic studies pinpointed this protein
riched region first referred to as the ‘‘factory’’ (Cairns,
as the target of rifampicin (Baldick et al., 1987; Tartaglia
1960) and the partially overlapping, phase-dense vac-
et al., 1986), a drug that can, reversibly, block the assem-
cinia protein-rich region which by convention has also
bly of the crescent (Grimley et al., 1970; Moss et al.,
been referred to as the viral factory (Sodeik et al., 1993).
1969). Under this condition large protein-rich aggregates
By electron microscopy these two parts of the factory
accumulate to which the precursor IV membranes ap-
are to a large extent distinct: the DNA-enriched regions,
pear to bind tightly (Sodeik et al., 1994, 1995). Following
visualized with anti-DNA antibodies and protein A-gold,
removal of the drug a reorganization of these membranes
are less dense than the factory regions that are enriched
occurs leading to a synchronous wave of crescent forma-
in many vaccinia proteins by immunocytochemistry (So-
tion first visible within a few minutes after reversal (Grim-deik et al., 1993). These two regions must somehow co-
ley et al., 1970).operate in the assembly of virions but our knowledge of
In the present study we have taken advantage of rifam-this process is fragmentary, at best.
picin to set up a novel in vitro assay designed to followThe first obvious ultrastructural event in the assembly
those steps in vaccinia assembly that occur after re-of a new infectious virion is the association of a tightly
versing rifampicin block. The strategy was as follows.apposed membrane cisterna (the crescent) enriched in
Cells were infected with vaccinia virus for 6–8 hr in theviral membrane proteins (Krijnse Locker et al., 1996; So-
presence of rifampicin and were subsequently perme-deik et al., 1995) with cytoplasmically encoded vaccinia
abilized with the pore-forming toxin, streptolysin O (SLO),proteins (Sodeik et al., 1994). This cisterna, which devel-
also in the presence of rifampicin. Following removal ofops into an incomplete sphere, is continuous with tubulo-
cytosolic components by buffer rinse, the rifampicin was
removed and the semi-intact cells were offered in vitro
environments aimed at facilitating in vitro assembly.1 Present address: Department of Cell Biology, Harvard University,
Boston, MA. These assembly steps of interest included the initial
2 Present address: Department of Cell Biology, Yale University School
‘‘budding’’ of the spherical (two-membraned) crescentsof Medicine, New Haven, CT 06510.
that give the spherical profiles of immature virus (IV) their3 To whom correspondence and reprint requests should be ad-
dressed. Fax: 049 6221 387306. characteristic appearance in thin sections. This process
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is followed by the events needed to allow the DNA to volume of a 10 times concentrated K-Ac buffer was added
(1150 mM potassium acetate, 25 mM magnesium ace-enter the particle. This DNA entry process is exceedingly
complex and is accompanied by a remarkable change tate, 250 mM HEPES buffer H, pH 7.4), followed by 10
more strokes. The cell breakage was checked by trypanin the shape of the particle from an almost perfect sphere
to a quasi brick-shaped structure—the intracellular ma- blue staining. The homogenate was centrifuged for 10
min at 17K in a SS-34-fixed angel rotor followed by ature virus (IMV) (Morgan, 1976; Dales and Pogo, 1981;
Sodeik et al., 1993; Ericsson et al., 1995) high speed centrigation of the supernatant (50K for 90
min in a Ti70 rotor). The resulting supernatant was snap-In the present report we describe our establishment
of this in vitro assay using rifampicin and SLO that en- frozen in liquid nitrogen and stored in the same medium.
For some experiments we also prepared cytosol fromables us to reconstitute one distinct morphological step
in the assembly of vaccinia virus, that begins with the uninfected cells or the cytochalasin D was omitted from
the cytosol preparation from infected cells.assembly of the crescent, and that ends at the stage
of an almost spherical particle, the stage immediately
Infection and permeabilization of cellspreceeding DNA entry. We show that both ATP and cyto-
sol are essential for this process. Hela cells were infected with WR in serum-free MEM
at a multiplicity of infection of 10. After 1 hr at 377 the
MATERIALS AND METHODS inoculum was removed, and the cells were washed with
PBS and overlaid with complete MEM containing 100Cells and viruses
mg/ml rifampicin (Sigma). After 8 to 15 hr of infection
HeLa cells were grown in Eagle’s minimal essential the cells were put on ice and rinsed twice in ice-cold
medium (MEM) supplemented with 10% heat-inactivated incubation-buffer (150 mM sucrose, 25 mM HEPES, pH
FCS and nonessential amino acids. Wild-type vaccinia 7.4, 115 mM Kac, 2.5 mM MgCl2 , 2 mM CaCO3/4 mM
virus WR was propagated in HeLa cells grown at 377 as EGTA) (IB) containing 100 mg/ml rifampicin. Rifampicin
previously described (Earl and Moss, 1991). was present during all the following incubation steps.
Cells were incubated with 2 U/ml streptolysin O (SLO;
Antibodies
Wellcome diagnostics) for 10 min on ice to allow the
toxin to bind to the plasma membrane. To remove un-The anti-DNA IgM was purchased from Boehringer
Mannheim GmbH (Mannheim, Germany). The mouse bound SLO, the cells were washed twice in IB containing
1 mM DTT and then permeabilized in this buffer by a 20-mAb anti-p14 (mAbC3) was a kind gift from Dr. M. Es-
teban (Rodriguez et al., 1985). The rabbit peptide sera min incubation at 377.
To determine the level of permeabilization, the cellsagainst p65 (Sodeik et al., 1994) and 4a (Ericsson et al.,
1995) were kindly provided by Dr. R. W. Doms. were stained with trypan blue and the release of lactate
dehydrogenase (LDH) was measured (Ahnert-Hilger et
Specific reagents al., 1989).
Reduced SLO was purchased from Wellcome diagnos-
In vitro assay
tics (Dartford, England). Hexokinase, creatine kinase,
and creatine phosphate were from Boehringer (Mann- After the permeabilization step described above the
infected cells were put on ice again and washed threeheim GmbH, Germany). ATP and protease inhibitors (kept
as 1000-fold stock solutions at0207 of 0.5 mg/ml leupep- times in IB without DTT and rifampicin during 15 min to
allow wash out of cytosolic components. The permeabil-tin, 1 mg/ml pepstatin, 0.5 mg/ml TPCK, and 4 mg/ml
aprotinin) were from Sigma. ized cells were subsequently incubated for 2 hr at 377 in
IB containing either an ATP-depleting system (37.5 U/ml
Preparation of HeLa cytosol hexokinase, 12.5 mM glucose) or an ATP-regenerating
system (1 mM ATP, 8 mM creatinine phosphate, 50 mg/Cytosol from Hela spinner cells was prepared as fol-
ml creatinine kinase) and cytosol (from Hela- or infectedlows. The spinner were infected overnight with a multi-
HeLa spinners prepared as described above) at a finalplicity of infection of 10. Cells were collected by centrifu-
concentration of 3 mg/ml. After the 2 hr in vitro the cellsgation for 10 min at 1500 rpm, and the pellets were
were fixed on the dish and prepared for electron micros-washed with PBS and again centrifuged. The cells were
copy as described below.swollen in ‘‘swelling-buffer’’ consisting of water con-
taining 1 mM EGTA, 1 mM MgCl2 , 1 mM DTT, 2 mM Electron microscopy
cytochalasin D (Sigma), and a protease inhibitor cocktail
(pepstatin, leupeptin, TPCK, and aprotinin). After swelling For Epon embedding cells were fixed for 60 min on
the dish in 1% glutaraldehyde in 200 mM cacodylatethe cells were broken by approximately 5 strokes of a
dounce homogenizer after which one-tenth of the total buffer, pH 7.4, stained with a mixture of 2% OsO4 and
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1.5% K[Fe(CN6)] for 1 hr and with 1% magnesium uranyl tinguished from unpermeabilized cells, mainly by their
gross loss of nuclear and cytoplasmic contents (Fig. 1).actetate for 30 min, then processed for conventional
Epon embedding. For preparation of cryosections the
permeabilized cells were overlaid with a 4% paraformal- In vitro assembly
dehyde/0.1% glutaraldehyde mixture and scraped in the
fixative with a teflon scraper. The cell suspension was Conditions were next sought which would allow rever-
sal of the rifampicin inhibition under in vitro conditions.centrifuged for 1 min and the pellet overlaid with 8%
paraformaldehyde in 250 mM HEPES, pH 7.4. Prior to For reference Fig. 2 shows the in vivo effects of rifampicin
(A) and a rifampicin reversal (B) in which immature virionsfreezing in liquid nitrogen the cell pellets were infiltrated
with 2.1 M sucrose in PBS for 15 min. Frozen samples are observed (see also Grimley et al., 1970). For the
in vitro studies, cells were infected in the presence ofwere sectioned at 0907, the sections were transferred to
Formvar-coated copper grids, and immunolabeling was rifampicin, permeabilized, and the endogenous cytosol
was released, also in the presence of rifampicin. Thecarried out as described elsewhere (Griffiths, 1993).
permeabilized cells were rinsed to remove the drug and
different media were added for periods of up to 4 hr. AtQuantitation of virus formation
the end of the incubation, these cells, as well as control
cells that were either continuously incubated with rifam-Cells infected with WR for 8 hr in the presence of
rifampicin, then permeabilized with SLO and incubated picin or not permeabilized, were prepared for thin section
EM. From in vivo experiments it appeared that the revers-in vitro for 2 hr under various conditions were used to
quantify virion formation in the in vitro assay. For this, ibility of rifampicin was quicker and more complete when
the infection was allowed to proceed for no longer thanepon sections from each sample were examined in the
electron microscope and the number of infected cells 6 to 8 hr. We therefore performed most of our in vitro
experiments using these times of infection.(crescents) (identified by the presence of rifampicin bod-
ies) containing budding profiles or IVs was counted using As shown in Figs. 1B and 2D, when the permeabilized
cells were washed free of rifampicin and incubated witha systematic sampling procedure (Griffiths, 1993). A cres-
cent was defined as a partially spherical profile where cytosol from vaccinia virus-infected Hela spinner cells in
the presence of an ATP-regenerating system, we ob-less than three-quarters of the circle was complete,
whereas an IV was scored when the profile was either served many cell profiles that contained large numbers
of IVs. In these experiments we had the impression thata complete circle or at least three-quarters of a circular
profile. For each sample 20 infected cells were exam- assembly of crescents and IVs was an all or none phe-
nomenon—we either saw many crescents/IVs in a cellined.
or we saw none. In the absence of either cytosol or ATP
the results (Fig. 3A) were indistinguishable from prepara-
RESULTS
tions that were incubated in vitro in the presence of rifam-
picin (Fig. 2C). We confirmed that ATP is essential forCell permeabilization
IV/IMV formation in vivo by blocking IV-formation with
rifampicin and then depleting ATP-levels with a mixtureCells were infected with vaccinia WR for 8 hr in the
presence of rifampicin (100 mg/ml). They were cooled of deoxy-D-glucose and sodium azide (Krijnse Locker et
al., 1994). The rifampicin was then washed out and theon ice, rinsed once with ice-cold PBS, and twice with
permeabilization buffer (see Materials and Methods) cells were incubated for a further 2 hr in either the pres-
ence or absence of ATP. Under the latter conditions nocontaining 1 mM dithiothretol. The cells were then incu-
bated for 10 min on ice with 2 units/ml SLO, after which IV particles were seen by EM (results not shown). The
level of IV-assembly seen using cytosol from infectedthe excess SLO was rinsed off. The cells were then
warmed to 377 for 20 min still in the presence of rifampi- cells was also seen when uninfected cell cytosol was
used in the presence of ATP. A quantitation of thesecin. This two-step procedure permits the permeabiliza-
tion of the plasma membrane only (Ahnert-Hilger et al., results is shown in Table 1.
During the in vitro assembly in the presence of cytosol1989; Krijnse Locker et al., 1994). Following this process
more than 90% of the cells became permeable to trypan and ATP the great majority of particles were in the cres-
cent or IV form. We arbitrarily define a crescent as ablue (not shown). Also after this time the release of lac-
tate dehydrogenase (LDH; Ahnert-Hilger et al., 1989) was discontinuous profile in a section, whereas an IV is de-
fined as a complete sphere or as an almost completelyestimated. On the average about 80% of the cell-associ-
ated LDH was released into the medium (not shown). spherical profile in the thin section. In the latter case
the profile covered at least three-quarters of the outerThe cells were then returned to ice temperature and
washed three times in a 15-min period. By EM thin sec- perimeter of a circle (see Fig. 2). A few intermediate
stage particles were occasionally seen which are mor-tion analysis the permeabilized cells could easily be dis-
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FIG. 1. (A) Low magnification plastic section to show the distinction between a SLO permeabilized HeLa cell (open star) and a nonpermeabilized
cell (closed star). (B) An overview of a rifampicin-blocked, permeabilized cell that was incubated, in the absence of rifampicin, with cytosol and
ATP for 60 min. Note the large numbers of budding IVs which have assembled in vitro (arrowheads). N, nucleus. Bars, 1 mm.
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FIG. 2. Epon sections of HeLa cells infected with vaccinia. (A) A cell that was treated in vivo with rifampicin; the asterisk denotes the electron-
dense, protein-rich ‘‘rifampicin-body.’’ (B) The rifampicin was washed out in vivo and IV assembly (arrowhead) allowed to continue for 15 min. (C
and D) Corresponding in vitro conditions: (C) continued inhibition by rifampicin under in vitro conditions and (D) in vitro assembly conditions. The
small arrowhead in C indicates membrane tubules that probably represent the vaccinia protein-modified intermediate compartment (see Sodeik et
al., 1993). The arrowhead in B indicates a crescent, defined as a partly spherical profile which is less than three quarters complete, whereas that
in D indicates an IV (completely spherical profile). The electron dense structures in B show the vaccinia DNA. Bars, 100 nm.
phologically distinct from the IV (Sodeik et al., 1994, erating system (0.5 to 3 mM). Taxol was used prior to
permeabilization in order to stabilize microtubules. It1995); these are more electron dense than the IV and
we previously showed that these forms are the first as- should be mentioned that depolymerization of microtu-
bules with nocodazole did not have an effect on thesembly stage to label with the IMV peripheral protein
P14 (see Figs 8 and 9 in Sodeik et al., 1995; results not reversibility of rifampicin in vivo (not shown). Dextran
(MW 10,000, 150 mM) was used instead of sucrose. Theshown). However, no mature IMV were ever seen in
these preparations. addition of reduced glutathione (GSH 2 mM), simulating
cytoplasmic reducing conditions, also made no differ-In addition to cytosol from vv-infected cells plus ATP
we tried the following conditions in order to assemble ence. Additional free calcium (by mixing 2 mM CaCO3
and 4 mM EGTA), which has been shown to be essentialthe viruses beyond the IV-stage, none of which were
successful. GTP was added in addition to the ATP-regen- for in vitro ER to Golgi transport, was also unsuccessful
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FIG. 3. Immunolabeling of in vitro-assembled IVs using thawed cryosections. (A and B) Labeling for p65, the target protein of rifampicin. (A) From
a cell incubated in vitro with vaccinia cytosol in the absence of ATP. Note the localization of the gold particles (arrowheads) on the periphery of
some parts of the electron-dense rifampicin bodies. (B) The permeabilized cell was incubated for 2 hr with vaccinia-infected cell cytosol and ATP.
Note the predominant localization of p65 on the inner aspect of the IV (asterisk), as in vivo. (C–E) Cells prepared similarly to B (ATP plus vaccinia
virus-cytosol) that were labeled for p4a (C), p14 (D), or with an anti-DNA antibody (E). The pattern of labeling for 4a (C) is indistinguishable from
the patterns seen after in vivo labeling. Similarly, p14 associates, as in vivo, with the periphery of the rifampicin body as well as with other
membranes; the budding IV profiles (asterisks) are invariably poorly labeled (a single gold particle is evident). (E) The majority of the labeling for
DNA is peripheral to the electron-dense rifampicin-body (star) as in vivo; the arrowhead denotes budding IVs. Bars, 100 nm.
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TABLE 1 vaccinia membranes at a stage intermediate between
the IV and the IMV (Sodeik et al., 1995). While antibodiesQuantitation of the in Vitro Results, Given as the Percentage
against this protein do not label the IV they label mem-of Cells Which Contain Assembled Crescents or IVs
branes continuous with the IV (Sodeik et al., 1995); as
Cells Percentage Percentage shown in Fig. 3D a similar labeling pattern is seen in
Condition counted of budding of IVs vitro. In vivo, a subset of particles intermediate between
the IV and the IMV label very strongly for p14 on theirHela VV-cytosol / ATP 20 70 15
periphery (Sodeik et al., 1995); only one or two individualHela VV-cytosol / ATP / PI 20 45 0
Hela VV-cytosol 20 0 0 examples of these labeled forms were seen in vitro (re-
Hela uninfected cytosol / ATP 20 70 15 sults not shown). As stated above, these particles tend
Hela in vivo VV-infected cells 20 nd 100 to be much more electron dense than most of the IVs.
As mentioned, we were never able to reconstitute theNote. VV, vaccinia virus infected; VV-cytosol, cytosol prepared from
in vitro assembly of stages distal to the IV form. Sinceinfected Hela spinners; ATP, ATP-regenerating system; PI, protease
inhibitors. A crescent is defined as a circular profile in a thin section these later stages coincide with the uptake of DNA into
which is less than three-quarters complete, whereas an IV is defined the virions we suspected that our failure to obtain in vitro
as having either a completely circular profile or showing more than assembly of the later stages might be due to the fact
three-quarters of a circle. Percentage of budding means the percentage
that the DNA was lost from the permeabilized cells. Weof cells which show any visible crescents or IVs. Percentage of IVs
therefore analyzed the localization of the vaccinia DNAmeans the percentage of cells which show any visible IVs, defined as
above. in the in vitro-assembled preparations. As shown in Fig.
3E, labeling with anti-DNA reveals a strong labeling of
electron dense material that is less dense than the pro-
(Beckers et al., 1989). Finally, omitting cytochalasin D tein-rich areas enriched in proteins such as 4a (A3L). This
during preparation of the cytosol made no difference. labeling was similar in both the presence and absence of
The addition of a cocktail of protease inhibitors (see Ma- ATP or cytosol. We have recently shown (Ericsson et al.,
terials and Methods) led to a significant decrease in 1995) that much of the condensed form of the DNA, which
the number of crescents and IVs that formed in vitro. is morphologically distinct (Grimley et al., 1970; Morgan,
Presumably, this reflects an inhibition of vaccinia prote- 1976), is associated with ER membranes and have spec-
ases that cleave a number of viral proteins at early stages ulated that this association might be important for the
of the morphogenesis but further studies are needed to entry of the DNA into assembling vaccinia particles. As
substantiate this point. shown in Figs. 4A and 4B, this association did not appear
to be affected by the absence of either ATP or cytosol
Immunolabeling
under in vitro conditions.
Further support for the notion that the IVs that assem-
DISCUSSIONbled in vitro were mostly indistinguishable from the nor-
mal IVs came from immunocytochemical labeling with The assembly of a large virus such as vaccinia in-
volves so many interrelated cell and viral processes thatselected antibodies against proteins which are enriched
in the IV stage. The first was p65 (the product of D13L), it is extremely difficult to dissect the molecular details
solely from in vivo studies. In recent years many complexwhich, from genetic studies, is the target of rifampicin
(Baldick et al., 1987; Tartaglia et al., 1986). We have shown processes central to cell biology have started to be suc-
cessfully analyzed using in vitro functional reconstitutionthat this protein localizes predominantly to the inner layer
of the two-membraned crescent, a localization consistent assays (e.g., Rothman and Orci, 1992). In the field of
membrane traffic many of the recent advances havewith the notion that this protein may behave as a scaffold
(Sodeik et al., 1994). As shown in Fig. 3B the localization come from the development of in vitro assays using semi-
intact cell systems where permeabilized cells are usedof p65 in the in vitro assembled IVs was indistinguishable
from their in vivo-assembled counterparts. When ATP under conditions where the overall organization of the
cell is not destroyed. One of the most popular reagentsand cytosol were omitted from the in vitro assembly
assay, p65 remained associated with the so-called rifam- for preparing semi-intact cells is streptolysin O (Ahnert-
Hilger et al., 1989), an approach we recently applied topicin bodies and did not associate with the viral factories
(Fig. 3A). Its localization thus appeared similar to the reconstitute in vitro transport from the rough ER to both
the intermediate compartment and the Golgi complexlocalization of p65 in unpermeabilized cells incubated in
the presence of rifampicin. Figure 3C shows the localiza- (Krijnse Locker et al., 1994). The great advantage of SLO
over most other approaches is its ability to selectivelytion of the core protein 4a (A3L), which again is very
similar to its in vivo labeling pattern (Ericsson et al., 1995). permeabilize the plasma membrane. It was therefore at-
tractive to try to set up an in vitro reconstitution systemThe protein p14 (A27L) is a peripheral outer membrane
protein that is acquired, probably posttranslationally, by for assembling vaccinia virus using SLO.
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FIG. 4. Epon sections of permeabilized, vaccinia-infected HeLa cells containing cytosol for 2 hr in the absence (A) or presence (B) of ATP. Note
the close association of the DNA fibrils (large arrowheads) with membranes that probably represent ER (arrows). The small arrowhead in B indicates
a tubular membrane profile, probably an element of the intermediate compartment (see Sodeik et al., 1993) in close apposition to the in vitro
assembled IV. The star indicates the rifampicin-body and N denotes the nucleus. Bars, 100 nm.
AID VY 8683 / 6a3f$$8683 07-31-97 00:11:28 viras AP: VY
226 ERICSSON ET AL.
The availability of rifampicin as an effective and revers- first step toward the goal of assembling an infectious
vaccinia IMV particle under in vitro conditions.ible inhibitor of IV assembly (Grimley et al., 1970; Moss
et al., 1969) provided us with a straightforward strategy We believe that the strategy introduced here for in vitro
reconstitution can be more generally applied to study thefor attempting the in vitro assembly of vaccinia. When
vaccinia infection is carried out in the presence of this in vitro assembly of other membrane viruses that are all
less complex than the pox viruses. The only prerequisitedrug there is essentially a complete block of IV assembly.
Within 5 to 10 min of washing out the drug under intact is the availability of a method to block assembly in vivo,
using, for example, a drug or a temperature-sensitivecell conditions a synchronous assembly of IVs is seen
(Grimley et al., 1970) that continue to make IMV over a mutant which can be reversed after SLO-permeabiliza-
tion. The method might not be suitable for membraneperiod of about 60 min (Grimley et al., 1970; our unpub-
lished observations). When the reversibility was allowed viruses that assemble by budding through the plasma
membrane since the SLO forms large pores in the latter.to take place after SLO permeabilization we could ask
whether any conditions would enable, first, IV and, sub- However, this problem could be overcome in the case of
those membrane viruses that bud preferentially throughsequently, IMV particles to assemble. By analogy to many
in vitro assays involving reconstitution of various mem- either the apical or basolateral domains of polarized cells
by selectively permeabilizing the opposite domain (Gra-brane traffic events (Gruenberg and Howell, 1989; Roth-
man and Orci, 1992) the first set of additives we used votta et al., 1990; Pimplikar et al., 1994).
for reconstitution attempts were cytosol plus ATP.
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